AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
阿斯利康支持的乳腺癌治疗正在接受欧洲监管机构的2型变更审核。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册